Aster DM Healthcare Limited has announced that a meeting of its equity shareholders will be convened on Tuesday, 10th March 2026, at 10:00 am IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The purpose of this meeting is to consider and approve, with or without modifications, the Scheme of Amalgamation between Aster DM Healthcare Limited and Quality Care India Limited, along with their respective shareholders and creditors, under Sections 230 to 232 of the Companies Act, 2013. Remote e-voting for the meeting will be open from Friday, 6th March 2026, at 9:00 a.m. IST until Monday, 9th March 2026, at 5:00 p.m. IST. The company has previously disclosed on February 4, 2026, that notices were issued for shareholder and creditor meetings to seek approval for this merger. The proposed merger aims to create one of the top 3 hospital chains in India and is described as the largest transaction in the hospital space in India. Shareholders have shown strong support, with an overwhelming majority (99.998%) approving the Share Swap preceding the merger. The company has also provided responses to stakeholder questions regarding the merger in Annexure 1. Key points highlighted include the merged entity's strong presence across India, a holistic platform with over 6,690 clinicians serving approximately 2.0 million patients quarterly, and expected EBITDA upside potential of 10-15% from identified synergies. The merger also outlines customary rights for promoters Aster Promoters and Blackstone, with provisions for director nomination rights that diminish with declining shareholding. Both promoter groups are committed to waiving certain rights to align with the highest standards of corporate governance and long-term stakeholder interests.
